HealthMore in Health→
Kidney disease drug development is finally building a deeper bench
Key Takeaways
- Nature Medicine says kidney disease is seeing a surge of targeted therapies after years of limited options.
- The emerging pipeline includes immunomodulators and genetically defined drugs.
- The story points to a structural shift in a field that has historically lacked new treatment depth.
DE
DT Editorial Team··via nature.com